129 related articles for article (PubMed ID: 36646586)
1. Pretreatment Platelet Count is a Prognostic Marker in Lung Cancer: A Danish Registry-based Cohort Study.
Sandfeld-Paulsen B; Aggerholm-Pedersen N; Winther-Larsen A
Clin Lung Cancer; 2023 Mar; 24(2):175-183. PubMed ID: 36646586
[TBL] [Abstract][Full Text] [Related]
2. Hyponatremia in lung cancer: Incidence and prognostic value in a Danish population-based cohort study.
Sandfeld-Paulsen B; Aggerholm-Pedersen N; Winther-Larsen A
Lung Cancer; 2021 Mar; 153():42-48. PubMed ID: 33454516
[TBL] [Abstract][Full Text] [Related]
3. Inflammation-scores as prognostic markers of overall survival in lung cancer: a register-based study of 6,210 Danish lung cancer patients.
Winther-Larsen A; Aggerholm-Pedersen N; Sandfeld-Paulsen B
BMC Cancer; 2022 Jan; 22(1):63. PubMed ID: 35027001
[TBL] [Abstract][Full Text] [Related]
4. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
Shao N; Cai Q
Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
[TBL] [Abstract][Full Text] [Related]
5. Hemoglobin, albumin, lymphocyte, and platelet score and neutrophil-to-lymphocyte ratio are novel significant prognostic factors for patients with small-cell lung cancer undergoing chemotherapy.
Yang N; Han X; Yu J; Shu W; Qiu F; Han J
J Cancer Res Ther; 2020 Sep; 16(5):1134-1139. PubMed ID: 33004760
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment Albumin-to-Alkaline Phosphatase Ratio Is a Prognostic Marker in Lung Cancer Patients: A Registry-Based Study of 7077 Lung Cancer Patients.
Sandfeld-Paulsen B; Aggerholm-Pedersen N; Winther-Larsen A
Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885242
[TBL] [Abstract][Full Text] [Related]
8. Platelet Count as a Prognostic Factor in Stage IV Non-Small Cell Lung Cancer.
Saha B; Khatun N; Azim N; Islam SA; Proteek MF; Islam MR; Begum FA; Biddut MA; Khan MK; Islam MR
Mymensingh Med J; 2022 Oct; 31(4):937-946. PubMed ID: 36189536
[TBL] [Abstract][Full Text] [Related]
9. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
Deng M; Ma X; Liang X; Zhu C; Wang M
Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
[TBL] [Abstract][Full Text] [Related]
10. Effects of reduced platelet count on the prognosis for patients with non-small cell lung cancer treated with EGFR-TKI: a retrospective study.
Xu L; Xu F; Kong H; Zhao M; Ye Y; Zhang Y
BMC Cancer; 2020 Nov; 20(1):1152. PubMed ID: 33243184
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the Clinical Utility of Circulating Tumor Cells at Different Time Points in Predicting Prognosis of Patients With Small Cell Lung Cancer: A Meta-Analysis.
Jiang AM; Zheng HR; Liu N; Zhao R; Ma YY; Bai SH; Tian T; Liang X; Ruan ZP; Fu X; Yao Y
Cancer Control; 2021; 28():10732748211050581. PubMed ID: 34654345
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of platelet count and lymphocyte to monocyte ratio combination in stage IV non-small cell lung cancer with malignant pleural effusion.
Lim JU; Yeo CD; Kang HS; Park CK; Kim JS; Kim JW; Kim SJ; Lee SH
PLoS One; 2018; 13(7):e0200341. PubMed ID: 30005083
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of combination of preoperative platelet count and mean platelet volume in patients with resectable non-small cell lung cancer.
Gao L; Zhang H; Zhang B; Zhang L; Wang C
Oncotarget; 2017 Feb; 8(9):15632-15641. PubMed ID: 28152504
[TBL] [Abstract][Full Text] [Related]
14. Nomograms Predict Overall Survival for Patients with Small-Cell Lung Cancer Incorporating Pretreatment Peripheral Blood Markers.
Xie D; Marks R; Zhang M; Jiang G; Jatoi A; Garces YI; Mansfield A; Molina J; Yang P
J Thorac Oncol; 2015 Aug; 10(8):1213-20. PubMed ID: 26200277
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of baseline hemoglobin-to-red blood cell distribution width ratio in small cell lung cancer: A retrospective analysis.
Wu F; Yang S; Tang X; Liu W; Chen H; Gao H
Thorac Cancer; 2020 Apr; 11(4):888-897. PubMed ID: 32087605
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of the preoperative platelet count and platelet-to-lymphocyte ratio (PLT-PLR) in patients with surgically resected non-small cell lung cancer.
Kim SH; Lee HW; Go SI; Lee SI; Lee GW
Oncotarget; 2016 Jun; 7(24):36198-36206. PubMed ID: 27105529
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of thrombocytosis in patients with primary lung cancer.
Pedersen LM; Milman N
Eur Respir J; 1996 Sep; 9(9):1826-30. PubMed ID: 8880098
[TBL] [Abstract][Full Text] [Related]
18. Peripheral Blood Lymphocytes and Platelets Are Prognostic in Surgical pT1 Non-Small Cell Lung Cancer.
Sulibhavi A; Asokan S; Miller MI; Moreira P; Daly BD; Fernando HC; Litle VR; Suzuki K
Ann Thorac Surg; 2020 Feb; 109(2):337-342. PubMed ID: 31593659
[TBL] [Abstract][Full Text] [Related]
19. Elevated platelet count is a strong predictor of poor prognosis in stage I non-small cell lung cancer patients.
Ji Y; Sheng L; Du X; Qiu G; Su D
Platelets; 2015; 26(2):138-42. PubMed ID: 24679181
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of the combined use of preoperative platelet count and serum carcinoembryonic antigen level in non-small-cell lung cancer.
Tomita M; Shimizu T; Ayabe T; Onitsuka T
Gen Thorac Cardiovasc Surg; 2010 Nov; 58(11):573-6. PubMed ID: 21069496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
